Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.81
-0.79 (-0.86%)
At close: Aug 17, 2026, 4:00 PM EDT
90.81
0.00 (0.00%)
After-hours: Aug 17, 2026, 6:30 PM EDT
Edwards Lifesciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,907 | 2,938 | 3,045 | 1,132 | 769 | 862.8 |
Short-Term Investments | 1,346 | 1,288 | 930.7 | 500.5 | 446.3 | 604 |
Cash & Short-Term Investments | 4,253 | 4,226 | 3,976 | 1,633 | 1,215 | 1,467 |
Cash Growth | 4.69% | 6.30% | 143.50% | 34.35% | -17.15% | 4.58% |
Accounts Receivable | 770.4 | 659.6 | 609.1 | 771.5 | 643 | 582.2 |
Other Receivables | 185.3 | 252.5 | 118.3 | 56.6 | 56.1 | 82.7 |
Receivables | 955.7 | 912.1 | 727.4 | 828.1 | 699.1 | 664.9 |
Inventory | 1,131 | 1,126 | 1,087 | 903.5 | 875.5 | 726.7 |
Prepaid Expenses | 119 | 135 | 121 | 128.8 | 110 | 85.2 |
Restricted Cash | 2.4 | 0.5 | 3.2 | 3.3 | 0.5 | 1.5 |
Other Current Assets | 357.9 | 338.8 | 371.2 | 539.2 | 195.4 | 235.6 |
Total Current Assets | 6,819 | 6,739 | 6,285 | 4,036 | 3,096 | 3,181 |
Property, Plant & Equipment | 1,942 | 1,915 | 1,784 | 1,675 | 1,725 | 1,639 |
Long-Term Investments | 244.1 | 278.6 | 307.9 | 583.9 | 1,239 | 1,834 |
Goodwill | 1,951 | 1,769 | 1,777 | 1,145 | 1,164 | 1,168 |
Other Intangible Assets | 1,383 | 1,128 | 1,177 | 399.4 | 285.2 | 323.6 |
Long-Term Deferred Tax Assets | 911.8 | 1,138 | 992.1 | 749.4 | 484 | 246.7 |
Other Long-Term Assets | 547.6 | 556.5 | 603.1 | 619.2 | 299.1 | 110.8 |
Total Assets | 13,867 | 13,697 | 13,055 | 9,363 | 8,293 | 8,503 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 210.5 | 227.5 | 197.4 | 186.6 | 201.9 | 204.5 |
Accrued Expenses | 954.4 | 1,065 | 790.4 | 667.2 | 593.1 | 643.4 |
Current Portion of Leases | 24.1 | 24.5 | 23.4 | 22.9 | 25.5 | 25.5 |
Current Income Taxes Payable | 192.9 | 192.5 | 286.6 | 52.7 | 50.6 | 30.6 |
Current Unearned Revenue | 20.3 | 27.2 | 53.7 | - | - | - |
Other Current Liabilities | 105.7 | 277 | 153.7 | 266 | 151.3 | 128.3 |
Total Current Liabilities | 1,508 | 1,814 | 1,505 | 1,195 | 1,022 | 1,032 |
Long-Term Debt | 598.7 | 598.3 | 597.7 | 597 | 596.3 | 595.7 |
Long-Term Leases | 81.6 | 82.6 | 78.9 | 65.2 | 69.5 | 69.1 |
Long-Term Unearned Revenue | - | 10.1 | 35.1 | - | - | - |
Pension & Post-Retirement Benefits | - | 28.9 | 32.1 | 36.2 | 23.5 | 41 |
Other Long-Term Liabilities | 954 | 826 | 743.4 | 750 | 774.1 | 928.6 |
Total Liabilities | 3,142 | 3,360 | 2,992 | 2,644 | 2,486 | 2,667 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 661.7 | 658.7 | 654.8 | 650.5 | 646.3 | 642 |
Additional Paid-In Capital | 2,976 | 2,768 | 2,613 | 2,274 | 1,969 | 1,700 |
Retained Earnings | 14,863 | 14,241 | 13,167 | 8,992 | 7,590 | 6,068 |
Treasury Stock | -7,668 | -7,092 | -6,192 | -5,025 | -4,144 | -2,417 |
Comprehensive Income & Other | -214.6 | -238.3 | -244.5 | -242.8 | -254.9 | -157.7 |
Total Common Equity | 10,618 | 10,338 | 9,998 | 6,650 | 5,807 | 5,836 |
Minority Interest | 106.9 | - | 64.5 | 69.4 | - | - |
Shareholders' Equity | 10,725 | 10,338 | 10,063 | 6,719 | 5,807 | 5,836 |
Total Liabilities & Equity | 13,867 | 13,697 | 13,055 | 9,363 | 8,293 | 8,503 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 704.4 | 705.4 | 700 | 685.1 | 691.3 | 690.3 |
Net Cash (Debt) | 3,577 | 3,528 | 3,281 | 947.7 | 524 | 776.5 |
Net Cash Growth | 6.31% | 7.51% | 246.25% | 80.86% | -32.52% | 9.72% |
Net Cash Per Share | 6.15 | 6.02 | 5.48 | 1.56 | 0.84 | 1.23 |
Filing Date Shares Outstanding | 576.4 | 580.8 | 587.9 | 601.3 | 608.31 | 623.21 |
Total Common Shares Outstanding | 576.6 | 580.7 | 588.6 | 601.1 | 608.3 | 624.1 |
Working Capital | 5,311 | 4,925 | 4,780 | 2,840 | 2,073 | 2,148 |
Book Value Per Share | 18.41 | 17.80 | 16.99 | 11.06 | 9.55 | 9.35 |
Tangible Book Value | 7,284 | 7,441 | 7,045 | 5,106 | 4,357 | 4,344 |
Tangible Book Value Per Share | 12.63 | 12.81 | 11.97 | 8.49 | 7.16 | 6.96 |
Land | - | 152.4 | 123.9 | 112.4 | 116.3 | 116.5 |
Buildings | - | 1,393 | 1,340 | 1,189 | 1,189 | 1,010 |
Machinery | - | 739.8 | 689.4 | 618.6 | 735 | 652.6 |
Construction In Progress | - | 301.2 | 244 | 292.5 | 255.2 | 333.8 |